HOME >> MEDICINE >> NEWS
Clinical study of Penn State Hershey technology begins in South Africa

The first clinical study of the neonatal chest wall stabilizer developed at Penn State Hershey Medical Center recently began at three hospitals in Johannesburg, South Africa.

Charles Palmer, M.B., Ch.B., device inventor and professor of pediatrics, Penn State College of Medicine, spent two weeks in August in South Africa where he trained medical staff to use the chest wall stabilizer, a device that allows babies with respiratory distress to breathe easier.

"Although the device could be an option for babies who need help with breathing in technologically-advanced hospitals like those in the United States, it could be particularly useful in developing countries where more expensive medical options are unavailable or in short supply," Palmer said.

The chest wall stabilizer was designed for premature babies who have underdeveloped, unstable chest walls that retract or buckle inward with each breath, making it difficult for them to breathe and get adequate oxygen. Palmer's lightweight device wraps around the chest wall and fastens to the skin of the chest and back with a non-irritating, water-soluble adhesive. The device is non-invasive, provides stability to the rib cage, restores the chest shape, permits chest expansion and has already been shown to allow easier breathing. Most importantly, this small device allows parents to hold the baby while they grow and heal.

The technology was recently patented and then licensed by Penn State to Respironics Inc., of Murraysville, Pa. Respironics is further developing it under the name, Hug 'n' Snug* Neonatal Chest Splint.

Although tested on an experimental basis in the United States, the first clinical study is taking place in South Africa where Palmer hopes the device will be available as soon as possible to help babies who do not have as many options as those in the United States. In the U.S., babies who are suffering from respiratory distress are given a substance called surfactant as well
'"/>

Contact: Valerie Gliem
vgliem@psu.edu
814-865-9481
Penn State
25-Aug-2003


Page: 1 2

Related medicine news :

1. Clinical breast examination offers modest benefit to breast cancer screening program
2. Clinical trial of Etanercept for Wegeners disease shows no benefit
3. Clinical trial participants fare no better, no worse than other patients
4. Clinical trial shows drug may offer a new option to prevent rejection of transplanted kidneys
5. National Academies news: Clinical research involving children
6. Clinical research key in advance to prospective health care
7. Clinical trial of new TB vaccine begins
8. Clinical trial of Alzheimers disease drug shows clear reductions in AD development
9. Clinical factors useful to identify heart failure patients with high risk of death
10. Panel: Clinical use of embryonic stem cells jeopardized by Bushs policy on federal funding
11. $7 million grant continues Asthma Clinical Research Network efforts

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... ... it has completed $3 million convertible note financing, which will be used to ... With the funds from this financing, the company will continue to expand its ...
(Date:8/31/2020)... PITTSBURGH (PRWEB) , ... August 31, 2020 , ... ... Allegheny Health Network (AHN), are joining biomedical engineers from Carnegie Mellon University (CMU) ... alternative for cardiac patients who have undergone open heart surgery. , The AGH/CMU ...
(Date:8/31/2020)... ... 31, 2020 , ... Want to get moving, break up your routine, and ... is thrilled to launch its fourth annual STEPtember campaign in the United States to ... everyone wherever they are at this moment — encouraging people to move in the ...
(Date:8/31/2020)... ... ... pandemic and topsy-turvy economic outlook continues to put financial strain on many of us, so ... fat from our monthly expenses and put more into savings, if possible. , “That’s a ... financial safety net in place in case something were to happen to you,” says Lee ...
(Date:8/31/2020)... ... August 31, 2020 , ... Bonde ... for patients with advanced heart failure, today announced that the company has been ... of $555,358 from the National Heart, Lung, and Blood Institute of the National ...
Breaking Medicine News(10 mins):
(Date:9/1/2020)... ... ... September is National Ovarian Cancer Awareness Month. Ovarian cancer is the ... the female reproductive system. The American Cancer Society estimates that in 2020, about ... from this disease. Throughout the month of September, Women’s Excellence aims to increase ...
(Date:8/31/2020)... ... August 31, 2020 , ... Cloudticity announced ... named Cloudticity a Gold winner in the 15th Annual 2020 Network PG’s IT ... o ns from Network Products Guide honoring achievements of world’s best in ...
(Date:8/27/2020)... ... August 27, 2020 , ... ... today announced the successful completion of their 2020 System and Organizational Controls (SOC) ... HITRUST® interim assessment and MARS-E compliance assessment. These achievements reflect their long-standing commitment ...
Breaking Medicine Technology:
Cached News: